000			01462 a2200409 4500
005			20250511202113.0
264		0	_c19920403
008			199204s 0 0 eng d
022			_a0923-2516
024	7		_a10.1016/0923-2516(91)90010-z _2doi
040			_aNLM _beng _cNLM
100	1		_aTilley, S A
245	0	0	_aA human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity. _h[electronic resource]
260			_bResearch in virology _c
300			_a247-59 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibody Specificity
650	0	4	_aBinding Sites
650	0	4	_aCD4 Antigens _ximmunology
650	0	4	_aDisulfides
650	0	4	_aEpitopes _ximmunology
650	0	4	_aHIV Envelope Protein gp120 _ximmunology
650	0	4	_aHIV Seropositivity _ximmunology
650	0	4	_aHIV-1 _ximmunology
650	0	4	_aHemophilia A _ximmunology
650	0	4	_aHumans
650	0	4	_aNeutralization Tests
650	0	4	_aSensitivity and Specificity
700	1		_aHonnen, W J
700	1		_aRacho, M E
700	1		_aHilgartner, M
700	1		_aPinter, A
773	0		_tResearch in virology _gvol. 142 _gno. 4 _gp. 247-59
856	4	0	_uhttps://doi.org/10.1016/0923-2516(91)90010-z _zAvailable from publisher's website
999			_c1730977 _d1730977